01 Shift from Conventional Applicators to Hybrid Intracavitary Interstitial Applicators Brachytherapy centers are increasingly adopting hybrid applicators that combine intracavitary components with interstitial needles, particularly for locally advanced cervical cancers with parametrial or asymmetric tumor extension. These systems allow clinicians to customize needle positioning and dose distribution within a single implant. For example, Elekta’s Venezia applicator combines intracavitary treatment with interstitial needle placement, supporting more conformal dose delivery while helping limit exposure to nearby organs.
02 Growing Adoption of Electronic Brachytherapy Another key market trend is the growing adoption of electronic brachytherapy systems that use miniature X-ray sources instead of conventional radioactive isotopes. Unlike traditional brachytherapy, electronic systems generate radiation electronically, eliminating the need to handle and store radioactive sources and simplifying certain radiation-safety requirements. For example, Xoft’s Axxent Electronic Brachytherapy System uses a miniature X-ray source to deliver localized radiation, supporting applications such as non-melanoma skin cancer treatment and enabling greater flexibility in outpatient treatment settings.
01 The brachytherapy market forecasts continued investment activity driven by the rising cancer treatment volumes and growing demand for precision radiation technologies. In July 2025, BrachyDOSE raised USD 639 thousand in seed funding led by Coinvest Capital, with participation from BSV Ventures and angel investor networks. The capital will support clinical testing, product development, and CE/MDR certification of its real-time radiation dose measurement technology for brachytherapy. The investment is intended to advance BrachyDOSE’s technology toward clinical adoption and commercialization.
01 The brachytherapy market has substantial exposure to supply chain disruptions due to its dependence on specialized radioactive sources, applicators, afterloaders, and precision components sourced from limited global suppliers. Disruptions in raw materials, radioactive isotope availability, manufacturing operations, transportation, and regulatory clearances are defining the market ecosystem by creating procurement challenges, extending equipment lead times, and increasing operational costs for healthcare providers worldwide. The market is experiencing an S-shaped recovery, characterized by an initial slowdown and accelerated recovery as manufacturers expand sourcing alternatives, improve inventory resilience, and restore production capacity.
01 Increasing Adoption of MRI-Guided Adaptive Brachytherapy and Growing Adoption of HDR Brachytherapy for Prostate Cancer Drive Market The growing use of MRI-guided adaptive brachytherapy is driving demand for advanced brachytherapy systems by enabling clinicians to visualize residual tumors and surrounding organs more precisely during treatment. Unlike conventional image-guided approaches, MRI-based planning supports individualized dose adaptation according to tumor geometry and organ-at-risk position. The EMBRACE-II treatment framework has strengthened the role of MRI-guided adaptive brachytherapy by emphasizing precise dose targets while maintaining strict limits for bladder, rectum, sigmoid, and bowel exposure.The increasing use of high-dose-rate brachytherapy in prostate cancer treatment is creating demand for advanced afterloaders, applicators, imaging systems, and treatment-planning software. HDR techniques allow radiation oncologists to deliver highly localized doses while adjusting treatment according to prostate anatomy and tumor characteristics. The availability of temporary radioactive-source placement also reduces the need for permanent implanted seeds in selected patients. This clinical flexibility is encouraging radiation oncology centers to expand HDR capabilities and invest in integrated image-guided brachytherapy infrastructure.
01 High Capital Costs of Applicators and Shortage of Specialized Radiation Oncology Personnel Restrain Market Expansion Brachytherapy requires specialized equipment, including afterloaders, MRI-compatible applicators, treatment-planning software, and imaging infrastructure, which can create substantial upfront investment for healthcare facilities. MRI-guided brachytherapy is particularly capital intensive because treatment centers may require compatible imaging systems, applicators, and dedicated treatment workflows. These costs can limit adoption among smaller hospitals and radiation centers, especially in emerging markets where healthcare budgets remain constrained.Brachytherapy procedures require coordinated expertise from radiation oncologists, medical physicists, radiation therapists, dosimetrists, and specialized nursing staff. Complex procedures involving interstitial implantation, image-guided planning, applicator placement, and real-time dose optimization require extensive training and workflow coordination. Limited availability of experienced personnel can reduce the number of procedures that centers are able to perform and increase treatment planning time.
01 Expansion of Brachytherapy for Recurrent Gynecological Cancers and Development of Patient-Specific Brachytherapy Applicators Offer Growth Opportunities to Market Players The increasing use of salvage brachytherapy for locally recurrent gynecological cancers presents an opportunity for manufacturers to develop more adaptable applicators and advanced image-guided treatment systems. Reirradiation requires precise dose delivery because previously treated tissues have limited tolerance to additional radiation. Advanced interstitial and hybrid applicators can support customized implantation around recurrent lesions while reducing exposure to surrounding organs. This creates opportunities for manufacturers offering flexible applicator designs.The development of patient-specific applicators using 3D printing is creating opportunities for manufacturers to address anatomical variations that conventional applicators cannot adequately accommodate. Customized devices are designed according to individual tumor location, surface geometry, and treatment requirements, potentially improving applicator positioning and dose conformity. This approach is particularly relevant for irregular skin, head-and-neck, and other anatomically challenging lesions. Manufacturers with capabilities in medical 3D printing, digital imaging, and treatment planning can leverage this opportunity to provide customized brachytherapy solutions.
01 Complex Radiation Safety Management and Patient Selection and Anatomical Variability Challenge Market Growth Handling high-activity radioactive sources remains a significant challenge for facilities using conventional high-dose-rate brachytherapy. Treatment centers must maintain secure source storage, controlled access, radiation monitoring, emergency procedures, and regulatory compliance throughout the source lifecycle. Short-lived isotopes such as iridium-192 also require periodic source replacement, creating additional logistical and operational requirements.Patient-specific anatomical differences can complicate applicator placement, dose distribution, and treatment reproducibility in brachytherapy procedures. Tumor location, organ movement, previous surgeries, and tissue changes may require customized implantation strategies and repeated imaging. These variations increase planning complexity and procedure time while making standardized treatment workflows more difficult.
November 2025 Unifeeder, CMC Vellore, and Amana launched CERVICARE THRICE, a cervical-cancer initiative that includes advanced Geneva brachytherapy applicators at CMC Vellore.
September 2025 BEBIG Medical participated in SFRO 2025 in Bordeaux and ASTRO 2025 in San Francisco, presenting its radiation-therapy portfolio.